Biological roles of lysophosphatidic acid signaling through its production by autotaxin

Biochimie

Volumn 92, Issue 6, 2010, Pages 698-706

  Okudaira, Shinichi ^a   Yukiura, Hiroshi ^a   Aoki, Junken ^a,b  

^a TOHOKU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Autotaxin; G protein coupled receptors; Lysophosphatidic acid; Lysophospholipid; Phospholipase

Indexed keywords

AUTOTAXIN; G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPASE; LYSOPHOSPHOLIPASE D; LYSOPHOSPHOLIPID; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ANGIOGENESIS; BIOCHEMISTRY; BRAIN DEVELOPMENT; CELL MOTILITY; ENZYME ACTIVITY; GENETIC DISORDER; HUMAN; KIDNEY FIBROSIS; KNOCKOUT MOUSE; LUNG FIBROSIS; MALIGNANT NEOPLASTIC DISEASE; NEUROPATHIC PAIN; NIDATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; HUMANS; LYSOPHOSPHOLIPIDS; MICE; MODELS, BIOLOGICAL; PHOSPHORIC DIESTER HYDROLASES; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION;

MUS;

EID: 77953288970     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.04.015     Document Type: Review

References (105)

1. Tokumura A. A family of phospholipid autacoids: occurrence, metabolism and bioactions. Prog. Lipid Res. 1995, 34:151-184.
2. Moolenaar W.H. Bioactive lysophospholipids and their G protein-coupled receptors. Exp. Cell Res. 1999, 253:230-238.
3. Tigyi G., Parrill A.L. Molecular mechanisms of lysophosphatidic acid action. Prog. Lipid. Res. 2003, 42:498-526.
4. van Meeteren L.A., Moolenaar W.H. Regulation and biological activities of the autotaxin-LPA axis. Prog. Lipid Res. 2007, 46:145-160.
5. Aoki J. Mechanisms of lysophosphatidic acid production. Semin. Cell Dev. Biol. 2004, 15:477-489.
6. Aoki J., Inoue A., Okudaira S. Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta 2008, 1781:513-518.
7. McIntyre T.M., Pontsler A.V., Silva A.R., St Hilaire A., Xu Y., Hinshaw J.C., Zimmerman G.A., Hama K., Aoki J., Arai H., Prestwich G.D. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc. Natl. Acad. Sci. 2003, 100:131-136.
8. Contos J.J., Fukushima N., Weiner J.A., Kaushal D., Chun J. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc. Natl. Acad. Sci. 2000, 97:13384-13389.
9. Inoue M., Rashid M.H., Fujita R., Contos J.J., Chun J., Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat. Med. 2004, 10:712-718.
10. Ye X., Hama K., Contos J.J., Anliker B., Inoue A., Skinner M.K., Suzuki H., Amano T., Kennedy G., Arai H., Aoki J., Chun J. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 2005, 435:104-108.
11. Pasternack S.M., von Kugelgen I., Aboud K.A., Lee Y.A., Ruschendorf F., Voss K., Hillmer A.M., Molderings G.J., Franz T., Ramirez A., Nurnberg P., Nothen M.M., Betz R.C. G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat. Genet. 2008, 40:329-334.
12. Shimomura Y., Wajid M., Ishii Y., Shapiro L., Petukhova L., Gordon D., Christiano A.M. Disruption of P2RY5, an orphan G protein-coupled receptor, underlies autosomal recessive woolly hair. Nat. Genet. 2008, 40:335-339.
13. Tanaka M., Okudaira S., Kishi Y., Ohkawa R., Iseki S., Ota M., Noji S., Yatomi Y., Aoki J., Arai H. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J. Biol. Chem. 2006, 281:25822-25830.
14. van Meeteren L.A., Ruurs P., Stortelers C., Bouwman P., van Rooijen M.A., Pradere J.P., Pettit T.R., Wakelam M.J., Saulnier-Blache J.S., Mummery C.L., Moolenaar W.H., Jonkers J. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol. Cell. Biol. 2006, 26:5015-5022.
15. van Corven E.J., Groenink A., Jalink K., Eichholtz T., Moolenaar W.H. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 1989, 59:45-54.
16. Hecht J.H., Weiner J.A., Post S.R., Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 1996, 135:1071-1083.
17. An S., Bleu T., Hallmark O.G., Goetzl E.J. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 1998, 273:7906-7910.
18. Bandoh K., Aoki J., Hosono H., Kobayashi S., Kobayashi T., Murakami-Murofushi K., Tsujimoto M., Arai H., Inoue K. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 1999, 274:27776-27785.
19. Noguchi K., Ishii S., Shimizu T. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 2003, 278:25600-25606.
20. Kotarsky K., Boketoft A., Bristulf J., Nilsson N.E., Norberg A., Hansson S., Owman C., Sillard R., Leeb-Lundberg L.M., Olde B. Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J. Pharmacol. Exp. Ther. 2006, 318:619-628.
21. Lee C.W., Rivera R., Gardell S., Dubin A.E., Chun J. GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J. Biol. Chem. 2006, 281:23589-23597.
22. Ishii S., Noguchi K., Yanagida K. Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat. 2009, 89:57-65.
23. Tabata K., Baba K., Shiraishi A., Ito M., Fujita N. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem. Biophys. Res. Commun. 2007, 363:861-866.
24. Murakami M., Shiraishi A., Tabata K., Fujita N. Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor. Biochem. Biophys. Res. Commun. 2008, 371:707-712.
25. An S., Bleu T., Zheng Y., Goetzl E.J. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. Mol. Pharmacol 1998, 54:881-888.
26. Contos J.J., Ishii I., Fukushima N., Kingsbury M.A., Ye X., Kawamura S., Brown J.H., Chun J. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol. Cell. Biol. 2002, 22:6921-6929.
27. Lee C.W., Rivera R., Dubin A.E., Chun J. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation. J. Biol. Chem. 2007, 282:4310-4317.
28. Yanagida K., Masago K., Nakanishi H., Kihara Y., Hamano F., Tajima Y., Taguchi R., Shimizu T., Ishii S. Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6. J. Biol. Chem. 2009, 284:17731-17741.
29. Yoshida K., Nishida W., Hayashi K., Ohkawa Y., Ogawa A., Aoki J., Arai H., Sobue K. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 2003, 108:1746-1752.
30. Hayashi K., Takahashi M., Nishida W., Yoshida K., Ohkawa Y., Kitabatake A., Aoki J., Arai H., Sobue K. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ. Res. 2001, 89:251-258.
31. Tokumura A., Iimori M., Nishioka Y., Kitahara M., Sakashita M., Tanaka S. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am. J. Phys. 1994, 267:C204-C210.
32. Jalink K., Hengeveld T., Mulder S., Postma F.R., Simon M.F., Chap H., van der Marel G.A., van Boom J.H., van Blitterswijk W.J., Moolenaar W.H. Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis. Biochem. J. 1995, 307(Pt 2):609-616.
33. Bandoh K., Aoki J., Taira A., Tsujimoto M., Arai H., Inoue K. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett. 2000, 478:159-165.
34. Shida D., Watanabe T., Aoki J., Hama K., Kitayama J., Sonoda H., Kishi Y., Yamaguchi H., Sasaki S., Sako A., Konishi T., Arai H., Nagawa H. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab. Invest. 2004, 84:1352-1362.
35. Hama K., Aoki J., Fukaya M., Kishi Y., Sakai T., Suzuki R., Ohta H., Yamori T., Watanabe M., Chun J., Arai H. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J. Biol. Chem. 2004, 279:17634-17639.
36. Tager A.M., LaCamera P., Shea B.S., Campanella G.S., Selman M., Zhao Z., Polosukhin V., Wain J., Karimi-Shah B.A., Kim N.D., Hart W.K., Pardo A., Blackwell T.S., Xu Y., Chun J., Luster A.D. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat. Med. 2008, 14:45-54.
37. Pradere J.P., Klein J., Gres S., Guigne C., Neau E., Valet P., Calise D., Chun J., Bascands J.L., Saulnier-Blache J.S., Schanstra J.P. LPA1 receptor activation promotes renal interstitial fibrosis. J. Am. Soc. Nephrol. 2007, 18:3110-3118.
38. Deng W., Shuyu E., Tsukahara R., Valentine W.J., Durgam G., Gududuru V., Balazs L., Manickam V., Arsura M., VanMiddlesworth L., Johnson L.R., Parrill A.L., Miller D.D., Tigyi G. The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology 2007, 132:1834-1851.
39. Lin S., Wang D., Iyer S., Ghaleb A.M., Shim H., Yang V.W., Chun J., Yun C.C. The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. Gastroenterology 2009, 136:1711-1720.
40. Panchatcharam M., Miriyala S., Yang F., Rojas M., End C., Vallant C., Dong A., Lynch K., Chun J., Morris A.J., Smyth S.S. Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure. Circ. Res. 2008, 103:662-670.
41. Lee Z., Cheng C.T., Zhang H., Subler M.A., Wu J., Mukherjee A., Windle J.J., Chen C.K., Fang X. Role of LPA4/p2y9/GPR23 in negative regulation of cell motility. Mol. Biol. Cell 2008, 19:5435-5445.
42. Tokumura A., Miyake M., Nishioka Y., Yamano S., Aono T., Fukuzawa K. Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of In vitro fertilization patients. Biol. Reprod. 1999, 61:195-199.
43. Sugiura T., Nakane S., Kishimoto S., Waku K., Yoshioka Y., Tokumura A. Lysophosphatidic acid, a growth factor-like lipid, in the saliva. J. Lipid Res. 2002, 43:2049-2055.
44. Hama K., Bandoh K., Kakehi Y., Aoki J., Arai H. Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors. FEBS Lett. 2002, 523:187-192.
45. Mauco G., Chap H., Simon M.F., Douste-Blazy L. Phosphatidic and lysophosphatidic acid production in phospholipase C-and thrombin-treated platelets. Possible involvement of a platelet lipase. Biochimie 1978, 60:653-661.
46. Gerrard J.M., Robinson P. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim. Biophys. Acta 1989, 1001:282-285.
47. Eichholtz T., Jalink K., Fahrenfort I., Moolenaar W.H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 1993, 291(Pt 3):677-680.
48. Sonoda H., Aoki J., Hiramatsu T., Ishida M., Bandoh K., Nagai Y., Taguchi R., Inoue K., Arai H. A novel phosphatidic acid-selective phospholipase A1 that produces lysophosphatidic acid. J. Biol. Chem. 2002, 277:34254-34263.
49. Hiramatsu T., Sonoda H., Takanezawa Y., Morikawa R., Ishida M., Kasahara K., Sanai Y., Taguchi R., Aoki J., Arai H. Biochemical and molecular characterization of two phosphatidic acid-selective phospholipase A1s, mPA-PLA1alpha and mPA-PLA1beta. J. Biol. Chem. 2003, 278:49438-49447.
50. Kazantseva A., Goltsov A., Zinchenko R., Grigorenko A.P., Abrukova A.V., Moliaka Y.K., Kirillov A.G., Guo Z., Lyle S., Ginter E.K., Rogaev E.I. Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH. Science 2006, 314:982-985.
51. Wen X.Y., Hegele R.A., Wang J., Wang D.Y., Cheung J., Wilson M., Yahyapour M., Bai Y., Zhuang L., Skaug J., Young T.K., Connelly P.W., Koop B.F., Tsui L.C., Stewart A.K. Identification of a novel lipase gene mutated in lpd mice with hypertriglyceridemia and associated with dyslipidemia in humans. Hum. Mol. Genet. 2003, 12:1131-1143.
52. Aoki J., Taira A., Takanezawa Y., Kishi Y., Hama K., Kishimoto T., Mizuno K., Saku K., Taguchi R., Arai H. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J. Biol. Chem. 2002, 277:48737-48744.
53. Bektas M., Payne S.G., Liu H., Goparaju S., Milstien S., Spiegel S. A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells. J. Cell Biol. 2005, 169:801-811.
54. Tokumura A., Harada K., Fukuzawa K., Tsukatani H. Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim. Biophys. Acta 1986, 875:31-38.
55. Tokumura A., Majima E., Kariya Y., Tominaga K., Kogure K., Yasuda K., Fukuzawa K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 2002, 277:39436-39442.
56. Umezu-Goto M., Kishi Y., Taira A., Hama K., Dohmae N., Takio K., Yamori T., Mills G.B., Inoue K., Aoki J., Arai H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 2002, 158:227-233.
57. Ferry G., Tellier E., Try A., Gres S., Naime I., Simon M.F., Rodriguez M., Boucher J., Tack I., Gesta S., Chomarat P., Dieu M., Raes M., Galizzi J.P., Valet P., Boutin J.A., Saulnier-Blache J.S. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J. Biol. Chem. 2003, 278:18162-18169.
58. Stracke M.L., Krutzsch H.C., Unsworth E.J., Arestad A., Cioce V., Schiffmann E., Liotta L.A. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. Biol. Chem. 1992, 267:2524-2529.
59. Bollen M., Gijsbers R., Ceulemans H., Stalmans W., Stefan C. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit. Rev. Biochem. Mol. Biol. 2000, 35:393-432.
60. Jansen S., Stefan C., Creemers J.W., Waelkens E., Van Eynde A., Stalmans W., Bollen M. Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J. Cell Sci. 2005, 118:3081-3089.
61. Koike S., Keino-Masu K., Ohto T., Masu M. The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as a signal peptide. Genes Cells 2006, 11:133-142.
62. Gijsbers R., Ceulemans H., Stalmans W., Bollen M. Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases. J. Biol. Chem. 2001, 276:1361-1368.
63. Stefan C., Jansen S., Bollen M. NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem. Sci. 2005, 30:542-550.
64. Morishige J., Touchika K., Tanaka T., Satouchi K., Fukuzawa K., Tokumura A. Production of bioactive lysophosphatidic acid by lysophospholipase D in hen egg white. Biochim. Biophys. Acta 2007, 1771:491-499.
65. Jansen S., Andries M., Derua R., Waelkens E., Bollen M. Domain interplay mediated by an essential disulfide linkage is critical for the activity and secretion of the metastasis-promoting enzyme autotaxin. J. Biol. Chem. 2009, 284:14296-14302.
66. Giganti A., Rodriguez M., Fould B., Moulharat N., Coge F., Chomarat P., Galizzi J.P., Valet P., Saulnier-Blache J.S., Boutin J.A., Ferry G. Murine and human autotaxin alpha, beta, and gamma isoforms: gene organization, tissue distribution, and biochemical characterization. J. Biol. Chem. 2008, 283:7776-7789.
67. Nakamura K., Ohkawa R., Okubo S., Yokota H., Ikeda H., Yatomi Y., Igarashi K., Ide K., Kishimoto T., Masuda A., Yamamoto T., Tsuji S., Saito N., Kurokawa M., Okudaira S., Aoki J. Autotaxin enzyme immunoassay in human cerebrospinal fluid samples. Clin. Chim. Acta 2009, 405:160-162.
68. Nakasaki T., Tanaka T., Okudaira S., Hirosawa M., Umemoto E., Otani K., Jin S., Bai Z., Hayasaka H., Fukui Y., Aozasa K., Fujita N., Tsuruo T., Ozono K., Aoki J., Miyasaka M. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions. Am. J. Pathol. 2008, 173:1566-1576.
69. Kanda H., Newton R., Klein R., Morita Y., Gunn M.D., Rosen S.D. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat. Immunol. 2008, 9:415-423.
70. Clair T., Aoki J., Koh E., Bandle R.W., Nam S.W., Ptaszynska M.M., Mills G.B., Schiffmann E., Liotta L.A., Stracke M.L. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res. 2003, 63:5446-5453.
71. Tsuda S., Okudaira S., Moriya-Ito K., Shimamoto C., Tanaka M., Aoki J., Arai H., Murakami-Murofushi K., Kobayashi T. Cyclic phosphatidic acid is produced by autotaxin in blood. J. Biol. Chem. 2006, 281:26081-26088.
72. Endo T., Kano K., Motoki R., Hama K., Okudaira S., Ishida M., Ogiso H., Tanaka M., Matsuki N., Taguchi R., Kanai M., Shibasaki M., Arai H., Aoki J. Lysophosphatidylmethanol is a pan lysophosphatidic acid receptor agonist and is produced by autotaxin in blood. J. Biochem. 2009, 146:283-293.
73. Baker D.L., Fujiwara Y., Pigg K.R., Tsukahara R., Kobayashi S., Murofushi H., Uchiyama A., Murakami-Murofushi K., Koh E., Bandle R.W., Byun H.S., Bittman R., Fan D., Murph M., Mills G.B., Tigyi G. Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis. J. Biol. Chem. 2006, 281:22786-22793.
74. Lee H.Y., Clair T., Mulvaney P.T., Woodhouse E.C., Aznavoorian S., Liotta L.A., Stracke M.L. Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin. J. Biol. Chem. 1996, 271:24408-24412.
75. Koike S., Keino-Masu K., Ohto T., Sugiyama F., Takahashi S., Masu M. Autotaxin/lysophospholipase D-mediated lysophosphatidic acid signaling is required to form distinctive large lysosomes in the visceral endoderm cells of the mouse yolk sac. J. Biol. Chem. 2009, 284:33561-33570.
76. Ye X., Skinner M.K., Kennedy G., Chun J. Age-dependent loss of sperm production in mice via impaired lysophosphatidic acid signaling. Biol. Reprod. 2008, 79:328-336.
77. Yang Y., Mou L., Liu N., Tsao M.S. Autotaxin expression in non-small-cell lung cancer. Am. J. Respir. Cell. Mol. Biol. 1999, 21:216-222.
78. Yang S.Y., Lee J., Park C.G., Kim S., Hong S., Chung H.C., Min S.K., Han J.W., Lee H.W., Lee H.Y. Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin. Exp. Metastasis 2002, 19:603-608.
79. Stassar M.J., Devitt G., Brosius M., Rinnab L., Prang J., Schradin T., Simon J., Petersen S., Kopp-Schneider A., Zoller M. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br. J. Cancer 2001, 85:1372-1382.
80. Baumforth K.R., Flavell J.R., Reynolds G.M., Davies G., Pettit T.R., Wei W., Morgan S., Stankovic T., Kishi Y., Arai H., Nowakova M., Pratt G., Aoki J., Wakelam M.J., Young L.S., Murray P.G. Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. Blood 2005, 106:2138-2146.
81. Zhang G., Zhao Z., Xu S., Ni L., Wang X. Expression of autotaxin mRNA in human hepatocellular carcinoma. Chin. Med. J. (Engl) 1999, 112:330-332.
82. Kishi Y., Okudaira S., Tanaka M., Hama K., Shida D., Kitayama J., Yamori T., Aoki J., Fujimaki T., Arai H. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J. Biol. Chem. 2006, 281:17492-17500.
83. Hama K., Aoki J., Bandoh K., Inoue A., Endo T., Amano T., Suzuki H., Arai H. Lysophosphatidic receptor, LPA3, is positively and negatively regulated by progesterone and estrogen in the mouse uterus. Life Sci. 2006, 79:1736-1740.
84. Van Leeuwen F.N., Olivo C., Grivell S., Giepmans B.N., Collard J.G., Moolenaar W.H. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1. J. Biol. Chem. 2003, 278:400-406.
85. Shida D., Kitayama J., Yamaguchi H., Okaji Y., Tsuno N.H., Watanabe T., Takuwa Y., Nagawa H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 2003, 63:1706-1711.
86. Ohta H., Sato K., Murata N., Damirin A., Malchinkhuu E., Kon J., Kimura T., Tobo M., Yamazaki Y., Watanabe T., Yagi M., Sato M., Suzuki R., Murooka H., Sakai T., Nishitoba T., Im D.S., Nochi H., Tamoto K., Tomura H., Okajima F. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol. Pharmacol. 2003, 64:994-1005.
87. Yamada T., Sato K., Komachi M., Malchinkhuu E., Tobo M., Kimura T., Kuwabara A., Yanagita Y., Ikeya T., Tanahashi Y., Ogawa T., Ohwada S., Morishita Y., Ohta H., Im D.S., Tamoto K., Tomura H., Okajima F. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J. Biol. Chem. 2004, 279:6595-6605.
88. Liu S., Umezu-Goto M., Murph M., Lu Y., Liu W., Zhang F., Yu S., Stephens L.C., Cui X., Murrow G., Coombes K., Muller W., Hung M.C., Perou C.M., Lee A.V., Fang X., Mills G.B. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 2009, 15:539-550.
89. Inoue M., Ma L., Aoki J., Chun J., Ueda H. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol. Pain 2008, 4:6.
90. Inoue M., Xie W., Matsushita Y., Chun J., Aoki J., Ueda H. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience 2008, 152:296-298.
91. Nakamura K., Igarashi K., Ide K., Ohkawa R., Okubo S., Yokota H., Masuda A., Oshima N., Takeuchi T., Nangaku M., Okudaira S., Arai H., Ikeda H., Aoki J., Yatomi Y. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin. Chim. Acta 2008, 388:51-58.
92. Nakamura K., Takeuchi T., Ohkawa R., Okubo S., Yokota H., Tozuka M., Aoki J., Arai H., Ikeda H., Ohshima N., Kitamura T., Yatomi Y. Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients. Ann. Clin. Biochem. 2007, 44:549-556.
93. Watanabe N., Ikeda H., Nakamura K., Ohkawa R., Kume Y., Aoki J., Hama K., Okudaira S., Tanaka M., Tomiya T., Yanase M., Tejima K., Nishikawa T., Arai M., Arai H., Omata M., Fujiwara K., Yatomi Y. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J. Clin. Gastroenterol. 2007, 41:616-623.
94. Nakamura K., Nangaku M., Ohkawa R., Okubo S., Yokota H., Ikeda H., Aoki J., Yatomi Y. Analysis of serum and urinary lysophospholipase D/autotaxin in nephrotic syndrome. Clin. Chem. Lab. Med. 2008, 46:150-151.
95. Tokumura A. Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids. Biochim. Biophys. Acta 2002, 1582:18-25.
96. Tokumura A., Kanaya Y., Miyake M., Yamano S., Irahara M., Fukuzawa K. Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy. Biol. Reprod. 2002, 67:1386-1392.
97. Tokumura A., Kume T., Fukuzawa K., Tahara M., Tasaka K., Aoki J., Arai H., Yasuda K., Kanzaki H. Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity. Life Sci. 2007, 80:1641-1649.
98. Tokumura A., Fukuzawa K., Tsukatani H. Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of different animal species. Lipids 1978, 13:572-574.
99. Yanagida K., Ishii S., Hamano F., Noguchi K., Shimizu T. LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line. J. Biol. Chem. 2007, 282:5814-5824.
100. Williams J.R., Khandoga A.L., Goyal P., Fells J.I., Perygin D.H., Siess W., Parrill A.L., Tigyi G., Fujiwara Y. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation. J. Biol. Chem. 2009, 284:17304-17319.
101. Kano K., Arima N., Ohgami M., Aoki J. LPA and its analogs-attractive tools for elucidation of LPA biology and drug development. Curr. Med. Chem. 2008, 15:2122-2131.
102. Parrill A.L., Baker D.L. Autotaxin inhibition: challenges and progress toward novel anti-cancer agents. Anti-cancer Agents Med. Chem. 2008, 8:917-923.
103. Jansen S., Andries M., Vekemans K., Vanbilloen H., Verbruggen A., Bollen M. Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. Cancer Lett. 2009, 284:216-221.
104. Brindley D.N., Pilquil C. Lipid phosphate phosphatases and signaling. J. Lipid Res. 2009, (50 Suppl):S225-S230.
105. Tomsig J.L., Snyder A.H., Berdyshev E.V., Skobeleva A., Mataya C., Natarajan V., Brindley D.N., Lynch K.R. Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo. Biochem. J. 2009, 419:611-618.